Clinical Trials Logo

Erysipelas clinical trials

View clinical trials related to Erysipelas.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT02032654 Terminated - Cellulitis Clinical Trials

Duration of ANtibiotic Therapy for CEllulitis

DANCE
Start date: August 26, 2014
Phase: Phase 4
Study type: Interventional

Cellulitis is among the most common infections leading to hospitalization, yet the optimal duration of therapy remains ill defined. Pragmatically, Dutch guidelines advise 10-14 days of antibiotics, which is the current standard of care. Recently it has been shown that antibiotic treatment for pneumonia and urinary tract infections can safely and significantly be shortened. Importantly, in an outpatient setting, treatment of uncomplicated cellulitis with 5 days of antibiotics was as effective as 10 days. We hypothesize that there is no difference in outcomes when patients hospitalized with cellulitis are treated with either a short-course (6 days) or standard-course (12 days) of antibiotics.

NCT ID: NCT01059123 Terminated - Erysipelas Clinical Trials

Short Course of Amoxicillin for Erysipelas

SHARE
Start date: September 2010
Phase: Phase 4
Study type: Interventional

The propose of this study is to determine whether a 6-day duration of oral amoxicillin treatment of erysipelas is non-inferior to a 14-day standard duration intravenous then oral amoxicillin regimen. This trial will be open but evaluation will be perform by a blind evaluator.